BFRI
Biofrontera·NASDAQ
--
--(--)
--
--(--)
BFRI fundamentals
Biofrontera (BFRI) expects to report earnings on Mar 19, 2026, with estimated revenue of 16.15M (YoY +28.58%), and EPS at 0.195 (YoY +202.63%).
Revenue estimate / YoY
16.15M
+28.58%
EPS estimate / YoY
0.195
+202.63%
Report date
Mar 19, 2026
Earnings Call
10:00 AM on Mar 19, 2026
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
BFRI has released its 2025 Q3 earnings report, with revenue of 6.99M, reflecting a YoY change of -22.46%, and net profit of -6.65M, showing a YoY change of -17.29%. The Sankey diagram below clearly presents BFRI's revenue sources and cost distribution.
Key Indicators
Biofrontera (BFRI) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Biofrontera (BFRI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Biofrontera (BFRI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Biofrontera (BFRI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Biofrontera (BFRI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Biofrontera (BFRI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Biofrontera's gross profit margin?What were the key takeaways from Biofrontera’s earnings call?What is the market's earnings forecast for Biofrontera next quarter?What factors drove the changes in Biofrontera's revenue and profit?What does Biofrontera do and what are its main business segments?What is the revenue and EPS growth rate for Biofrontera year over year?What guidance did Biofrontera's management provide for the next earnings period?What were the key takeaways from Biofrontera's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
